JMN Financial’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
JMN Financial's NVS Position: Q3 2026 in Review
JMN Financial increased its Novartis (NVS) stake by 1.8% in Q3 2026, buying an estimated $14.3K and bringing the position to 5,183 shares worth $739K. The position accounts for 0.59% of the portfolio, ranked #35.
JMN Financial first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $872K in Q4 2025. 1,554 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- JMN Financial held 5,183 shares of Novartis worth $739K as of Q3 2026.
- JMN Financial bought 94 Novartis shares in Q3 2026, an estimated $14.3K.
- Novartis made up 0.59% of JMN Financial's portfolio in Q3 2026, its #35 holding.
- JMN Financial first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
- JMN Financial's Novartis position peaked at $872K in Q4 2025.
- 1,554 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on JMN Financial's 13F filing for Q3 2026, filed 10 Nov 2026.